Favorable Outcomes of Liver Transplantation from Controlled Circulatory Death Donors Using Normothermic Regional Perfusion Compared to Brain Death Donors

Éric Savier(Sorbonne Université), Chétana Lim(Sorbonne Université), Michel Rayar(Hôpital Pontchaillou), Francesco Orlando(Hôpital Pontchaillou), Karim Boudjéma(Hôpital Pontchaillou), Kayvan Mohkam(Université Claude Bernard Lyon 1), Mickaël Lesurtel(Université Claude Bernard Lyon 1), Jean Yves Mabrut(Université Claude Bernard Lyon 1), Gabriella Pittau(Université Paris-Sud), Nassiba Begdadi(Université Paris-Sud), Daniel Cherqui(Université Paris-Sud), René Adam(Université Paris-Sud), Fédérica Dondero(Hôpital Beaujon), Ailton Sepulveda(Hôpital Beaujon), Olivier Soubrane(Hôpital Beaujon), Petru Bucur(Centre Hospitalier Universitaire de Tours), Louise Barbier(Inserm), Ephrem Salamé(Inserm), Carine Jasseron(Agence de la Biomédecine), Corinne Antoine(Agence de la Biomédecine), Bruno Riou(Sorbonne Université), Olivier Scatton(Sorbonne Université)
Transplantation
June 29, 2020
Cited by 100

Abstract

BACKGROUND: Liver transplantation (LT) from controlled donation after circulatory death (cDCD) was initiated in France in 2015 under a protocol based on the use of normothermic regional perfusion (NRP) before organ procurement. The aim was to compare outcomes following cDCD LT with NRP and donation after brain death (DBD) LT. METHODS: This is a multicenter retrospective study comparing cDCD LT with NRP and DBD LT. A case-matched study (1:2) was performed using the variables such as recipient and donor age, indication of LT. RESULTS: A total of 50 patients from the cDCD group were matched to 100 patients from the DBD group. From postoperative days 1-4, serum transaminase release was significantly lower in the cDCD group compared to the DBD group (P < 0.05). Early allograft dysfunction (cDCD: 18% versus DBD: 32%; P = 0.11), acute kidney injury (26% versus 33%; P = 0.49), 90-d graft loss (2% versus 5%; P = 0.66), and arterial (4% versus 12%; P = 0.19) and biliary (16% versus 17%; P = 0.94) complications were similar between the 2 groups. The 2-y graft survival was 88% for cDCD group and 85% for DBD group (P = 0.91). The 2-y patient survival was 90% for cDCD group and 88% for DBD group (P = 0.68). CONCLUSIONS: This study provides evidence that cDCD LT following postmortem NRP can be safely and effectively performed in selected recipients with similar graft and patient survival outcomes, without increased rates of biliary complications and early graft dysfunction compared to DBD LT.


Related Papers

No related papers found

Powered by citation graph analysis